Chlamydia Screening & Treatment
Published on: 19th July 2013 | Updated on: 15th March 2022
Examples of this service that have been commissioned locally are available on the PSNC online services database.
Tools and publications which may be useful to support the commissioning of this service can be found on the Service development tools and publications hub.
Click on a heading below for more information.
Chlamydia Screening & Treatment template service specification (Microsoft Word)
Above, is a nationally negotiated template service specification (developed and agreed by PSNC, the Department of Health and NHS Employers). LPCs and contractors are able to negotiate to provide services in accordance with this specification where a local need for the service is determined. Alternatively LPCs, contractors or the service commissioner are free to develop their own local services in response to identified needs.
The PSNC resource Community Pharmacy – at the Heart of Public Health describes the main public health services that are provided by community pharmacies and the evidence base for these services.
Public Health England & Royal Society for Public Health – Everyday interactions (June 2017)
This resource aims to support healthcare professionals to record what they ‘do’ in their interactions with individuals to demonstrate impact on public health priorities.
Public Health England (PHE) published guidance for local authority commissioners in November 2014 – Information to support the commissioning of chlamydia screening in general practice and community pharmacies. The document explains about some of the benefits of commissioning the service from primary care providers such as community pharmacies and general practices and it suggests elements that should be included in service specifications for the service.
The Professional Standards for Public Health Practice for Pharmacy (Mar 2014) provide a framework to help pharmacy teams, commissioners and those contracting services to design, implement, deliver and monitor high quality public health practice through pharmacy.
PHE has published a package of resources providing the latest evidence on the impact and economics of opportunistic chlamydia screening, and HIV screening and testing. The topics were selected given their priority as key sexual health indicators within the ‘Public Health Outcomes Framework’, which local areas are now delivering against.
For both subjects, PHE has produced:
- Evidence Summaries: a full review of the latest evidence on opportunistic chlamydia screening and HIV screening and testing including cost-efficacy, impact, acceptability etc. PHE hopes these will underpin public health leaders’ planning and evaluation of local services.
- Leaders’ Briefings: covering frequently asked questions and considerations for local action. PHE hopes public health leaders will find these useful to brief senior local authority and other commissioning staff on these 2 topics.
For more information on this topic please email firstname.lastname@example.org